Net sales was up by 54 per cent to Rs 3181 crores
Alembic Pharmaceuticals has posted its audited financial results for the year ending March 31, 2016. The company has reported a 54 per cent rise in net sales to Rs 3181 crores and the net profit was up 154 per cent to Rs 719 crores.
The international formulation business grew 146 per cent to Rs 1462 crores.
Pranav Amin, Managing Director, Alembic Pharmaceuticals, “This has been an outstanding year for the company. R&D will continue to remain a thrust area and we hope to strengthen our portfolio rapidly in the years to come. The recent JV with Orbicular will help establish our presence in the dermatology segment.”
EP News Bureau – Mumbai